Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butorphanol tartrate plus dexmedetomidine versus sufentanil for analgesia in mechanically ventilated ICU patients
ChiCTR2000038721Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- Oct 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of butorphanol, dexmedetomidine and sufentanil in pain and agitation (2 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoints: Dosage of analgesics, Dosage of sedative drugs and 3 more. Started Oct 2020; status: recruiting.
02
Drugs
butorphanoldexmedetomidinesufentanil
03
Conditions
painagitation
Beyond the preview
Go deeper on ChiCTR2000038721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038721.